Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy.

Por Hirsch, E C, Graybiel, A M, Duyckaerts, C, Javoy-Agid, F
Publicado em 1987

Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.

Por Jegou, S, Javoy-Agid, F, Delbende, C, Ruberg, M, Vaudry, H, Agid, Y
Publicado em 1985

Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain

Por Strada, O, Hirsch, EC, Javoy-Agid, F, Lehericy, S, Ruberg, M, Hauw, JJ, Agid, Y
Publicado no J Neurosci (1992)

Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.

Por Strada, O, Vyas, S, Hirsch, E C, Ruberg, M, Brice, A, Agid, Y, Javoy-Agid, F
Publicado em 1992

Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.

Por Epelbaum, J, Javoy-Agid, F, Hirsch, E, Hauw, J J, Kordon, C, Krantic, S, Agid, Y
Publicado em 1987

Noradrenaline, adrenaline and tyrosine hydroxylase in adrenal medulla from parkinsonian patients.

Por Cervera, P, Rascol, O, Ploska, A, Gaillard, G, Raisman, R, Duyckaerts, C, Hauw, J J, Scherman, D, Montastruc, J L, Javoy-Agid, F
Publicado em 1988